REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea · Delayed Price · Currency is KRW 9,960.00
-80.00 (-0.80%)
Apr 2, 2026, 3:30 PM KST
REYON Pharmaceutical Revenue
REYON Pharmaceutical had revenue of 37.58B KRW in the quarter ending September 30, 2025, a decrease of -1.86%. This brings the company's revenue in the last twelve months to 149.34B, down -0.33% year-over-year. In the year 2024, REYON Pharmaceutical had annual revenue of 148.30B, down -1.83%.
Revenue (ttm)
149.34B
Revenue Growth
-0.33%
P/S Ratio
1.22
Revenue / Employee
339.42M
Employees
448
Market Cap
182.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 148.30B | -2.77B | -1.83% |
| Dec 31, 2023 | 151.07B | -2.97B | -1.93% |
| Dec 31, 2022 | 154.04B | 11.24B | 7.87% |
| Dec 31, 2021 | 142.80B | 12.77B | 9.82% |
| Dec 31, 2020 | 130.03B | -1.52B | -1.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Suheung | 722.31B |
| Jeil Pharmaceutical Co.,Ltd | 567.24B |
| Dongwha Pharm.Co.,Ltd | 496.39B |
| Kyongbo Pharmaceutical | 264.10B |
| JW Lifescience | 257.83B |
| Whan In Pharm | 255.21B |
| Samil Pharmaceutical Co.,Ltd | 215.04B |
| Daihan Pharmaceutical | 208.61B |